Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis

Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis

ABSTRACT Background Hepatitis B virus (HBV) infection causes liver disease, including hepatocellular carcinoma. Controlling viral activity is crucial to reducing complications. Tenofovir may offer benefits over entecavir, but it is unclear if switching from entecavir to tenofovir improves outcomes....

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Shahzil, Ammad Javaid Chaudhary, Talha Kashif, Ali Akram Qureshi, Anza Muhammad, Faiza Khan, Muhammad Saad Faisal, Muhammad Ali Khaqan, Hassam Ali, Yara Dababneh, Dilip Moonka
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:JGH Open
Subjects:
antiviral agents
chronic
drug substitution
entecavir
hepatitis B
tenofovir
Online Access:https://doi.org/10.1002/jgh3.70055
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jgh3.70055

Similar Items